One of the most important research areas in case-control Genome-Wide Association Studies is to determine how the effect of a genotype varies across the environment or to measure the gene-environment interaction (GxE). We consider the scenario when some of the "healthy" controls actually have the disease and when the frequency of these latent cases varies by the environmental variable of interest. In this scenario, performing logistic regression of clinically defined case status on the genetic variant, environmental variable, and their interaction will result in biased estimates of GxE interaction. Here, we derive a general theoretical approximation to the bias in the estimates of the GxE interaction and show, through extensive simulation, that this approximation is accurate in finite samples. Moreover, we apply this approximation to evaluate the bias in the effect estimates of the genetic variants related to mitochondrial proteins a large-scale Prostate Cancer study.
bin/study. cgi?study_id=phs000207.v1.p1, Yeager et al, 2007) . Finally, we conclude our paper with a brief Discussion section. For clarity of presentation we suppose that all variables are binary, but the discussion could be easily extended to categorical variables, though the interpretation of GxE can then be notoriously difficult.
MATERIALS AND METHODS

For
If ߠ is the frequency of minor allele a when the major allele is A, then the Hardy-Weinberg Equilibrium model (Hardy, 1908) states
We assume that individuals with a clinical diagnosis have the true disease, i.e.
and that a substantial proportion of "controls" also have the true disease and that this proportion can vary by environmental factors:
We next assume that the probability of the true disease follows a logistic model p r
to be the vector of coefficients of interest.
The observed data are collected using retrospective sampling design, hence the likelihood function of the observed data is based on the probability
The usual analyses with the clinical diagnosis as an outcome variable and hence ignores presence of silent disease is based on the disease risk model
Estimation and inference in this setting is performed based on the likelihood function in the form
We are interested to find an analytic solution that relates parameters
We define
Derivations shown in Appendix arrive at the following approximation of the relationship between the parameters of the misspecified model (4) 
We now derive alternative formulation. In retrospective design cases and controls are sampled conditionally on the disease status. We therefore introduce an imaginary indicator of being selected into the study, ∆ ൌ 1
. Cases and controls are then selected into the study with probabilities
We then derive
Remarks: 
. That is then the usual logistic regression model yields consistent estimate of the null effect of ߚ ீ ൈ . 9. Taylor series expansion of (10)-(13) around the true parameters equal to zero arrives to (6)-(9).
SIMULATION EXPERIMENTS
We first perform a set of simulation studies to investigate a false positive rate for 
. We then estimate bias in estimates of 
is on average 0.08, while the bias is approximated to be -0.82. Shown on Figure 5A is the histogram of bias in ߚ ீ across 1,975 SNPs that ranges from -0.19 to 0.20 with an average of 0.0042. Shown on Figure 5B is the histogram of bias in ߚ ீ ൈ ranging from -1.87 to 0.81 with an average of -0.07.
DISCUSSION
We derived a general and convenient theoretical approximation to the bias in The approximation that we've developed is a first order Taylor series expansion of a solution that minimizes Kullback-Leibler divergence criteria between the true and the misspecified models. While the Kullback-Leibler divergence could have multiple local minima, in the extensive simulations studies that we considered the numerical optimization did find the minimum that was accurate relative to the empirical estimates. The theoretical approximation can be improved by deriving further order Taylor series expansions.
We note that the bias in GxE generally decreases as the frequency of the true disease and the clinical diagnosis decrease. The magnitude of bias, however, can be substantial even when the disease is common, similarly to what has been described for common diseases in trio designs (Peyrot et al, 2016 
